The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth

BACKGROUND: Previous work has demonstrated immunomodulatory, anti-tumor, anti-metastatic and anti-angiogenic effects of the small molecule quinoline-3-carboxamide tasquinimod in pre-clinical cancer models. To better understand the anti-tumor effects of tasquinimod in transplantable tumor models, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Deronic, Adnan, Leanderson, Tomas, Ivars, Fredrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939705/
https://www.ncbi.nlm.nih.gov/pubmed/27400708
http://dx.doi.org/10.1186/s12885-016-2481-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939705/
https://www.ncbi.nlm.nih.gov/pubmed/27400708
http://dx.doi.org/10.1186/s12885-016-2481-0

Ejemplares similares